Search
Animal Health Partnering Interests Oncology May 2024 CORP
oncology_flyer_bio_05-2020.pdf
Nintedanib_in_Oncology_Backgrounder.pdf
Oncology_Flyer_BIO_2022.pdf
Partnering_In_Oncology_0422.pdf
Partnering_In_ONCOLOGY_0.pdf
Partnering in Oncology MAY 2024 CORP_0.pdf
Partnering in Oncology JAN 2023 Corporate
Partnering in Oncology JAN 2023 Corporate
bi_in_oncology_backgrounder.pdf
bi_oncology_backgrounder3.0_approved.pdf
Oncology_Partnering_Interests-2018-12.pdf
Oncology_Backgrounder_05_2016.PDF
2015 09 18 BI in Oncology Backgrounder_6.0_ohne694.pdf
Partnering in Oncology & Cancer Imm HP OCTOBER 2024 CORP.pdf
Vienna
Vienna is a cornerstone within the company’s global R&D network, with a special focus on cancer research. On top of that, it is also a hub for biopharmaceutical development and production.
Sustainable medicines that help minimize environmental impact
How we collaborate with renowned experts to lead the way in reducing solvent waste, as part of our efforts to embed sustainability into our core business.
vet scholars symposium
Veterinary students and researchers from 38 veterinary schools in North America and Europe gathered at the NIH in August to discuss the future of veterinary medicine.
R&D - Transforming tomorrow
Manami Tsutsumi, Senior Associate Director in Research & Development describes what it's like working on the cutting edge of pharmaceutical development.
Our_Inflammatory_Disease_Research.pdf
Research Beyond Borders Infographic
Clinical_Research_2015.pdf
Respiratory Research and Development Timeline.pdf
Biotherapeutics Discovery
We are applying our deep understanding of disease biology to design a diverse range of novel modalities that are the foundation for life-changing biotherapeutics for patients.